Waking Up to Urinate on TRT?

Viewing This Video Is A Member Exclusive Feature

But you don’t need membership to get Dr. O’Connor’s insight on this topic, it’s in the summary, key takeaways, and related drugs and conditions below.

Want to watch the full video? Join the Health Portal Today.

Join Now

Already a member? Sign In

Timeline

00:00

A 43-year-old man using testosterone and “Retta” asks why he has started urinating four to six times each night. Dr. O’Connor considers prostate-related urinary symptoms and introduces retatrutide’s receptor activity while discussing possible medication effects.

01:50

Dr. O’Connor returns to possible explanations for the nighttime urination, including benign prostatic hyperplasia, testosterone-related worsening of urinary symptoms, and excessive fluid intake. He also questions the quality of the viewer’s retatrutide product and explains why he is not prescribing the compound at the time of recording.

03:40

The clinical discussion gives way to announcements about supplements and access to testosterone care through the Testosteronology Health Portal. Dr. O’Connor introduces MyCare MD and distinguishes its healthcare providers from his own practice.

05:30

Dr. O’Connor describes medication and laboratory access through the portal while repeatedly encouraging viewers to use healthcare providers. The closing remarks return to his supplement offerings and his emphasis on obtaining care from providers he considers qualified.

Video Summary

Waking four to six times a night to urinate raises questions about more than testosterone alone. Dr. Thomas O’Connor responds to a 43-year-old man using testosterone and a product described as “Retta,” exploring whether prostate symptoms, fluid intake, or medication effects could be contributing.

Dr. O’Connor initially considers testosterone an unlikely explanation by itself, then discusses benign prostatic hyperplasia and lower urinary tract symptoms as possible factors. He explains that testosterone can worsen these symptoms and raises lowering the dose and reconsidering excessive water intake as issues relevant to the viewer’s situation.

The discussion also examines retatrutide and its activity at GIP, GLP-1, and glucagon receptors. Although Dr. O’Connor does not identify it as the expected cause of the nighttime urination, he acknowledges uncertainty about side effects and questions the identity and quality of the product the viewer is taking. He states that he is not prescribing retatrutide at the time of recording.

The second half shifts to supplements, the Testosteronology Health Portal, and access to healthcare through MyCare MD. Dr. O’Connor describes the providers as separate from his own practice and repeatedly emphasizes using healthcare professionals when obtaining testosterone, other medications, and laboratory testing.

The main clinical message is that frequent nighttime urination during TRT should not automatically be attributed to one drug. Prostate-related symptoms, testosterone exposure, fluid intake, and uncertainty about other products all enter the discussion, without a definitive diagnosis being established for the viewer.

Drug Callouts

Testosterone

Testosterone is an androgen hormone prescribed as replacement therapy for testosterone deficiency. Dr. O’Connor explains that it can worsen lower urinary tract symptoms and raises dose reduction as a consideration in his response to the viewer’s frequent nighttime urination.

Retatrutide

Retatrutide is a drug compound that activates GIP, GLP-1, and glucagon receptors. Discussing the viewer’s “Retta” use, Dr. O’Connor acknowledges uncertainty about side effects and product quality without establishing it as the cause of the urinary symptoms.

Tirzepatide

Tirzepatide is a medication that activates GIP and GLP-1 receptors to help regulate blood glucose and appetite. It serves as a comparison when Dr. O’Connor explains retatrutide’s additional activity at the glucagon receptor.

Condition Callouts

Nighttime Urination

Nighttime urination, also called nocturia, means waking from sleep to pass urine. The viewer reports four to six episodes nightly over the preceding months, prompting consideration of prostate symptoms, testosterone exposure, fluid intake, and possible medication effects.

Benign Prostatic Hyperplasia (BPH)

Benign prostatic hyperplasia is noncancerous enlargement of the prostate that can interfere with urination. Dr. O’Connor raises BPH as one possible explanation for the viewer’s symptoms rather than confirming a diagnosis.

Lower Urinary Tract Symptoms (LUTS)

Lower urinary tract symptoms are a group of bladder and urinary symptoms involving urine storage, passage, or emptying. Dr. O’Connor identifies LUTS as a possible framework for the viewer’s complaints and explains that testosterone can worsen them.

Key Takeaways

Frequent nighttime urination during TRT does not establish testosterone as the sole cause; prostate symptoms, fluid intake, and other products may also contribute.
Testosterone can worsen lower urinary tract symptoms, making dose an important part of the discussion when urinary problems develop.
Benign prostatic hyperplasia is a possible explanation for urinary symptoms, but a symptom report alone does not confirm that diagnosis.
Excessive water intake is worth reviewing when repeated nighttime bathroom trips disrupt sleep.
Uncertainty about a product’s identity and quality makes it harder to interpret its effects or determine whether it is contributing to symptoms.
Access to medications, laboratory testing, and educational resources should be paired with involvement from qualified healthcare providers.